Literature DB >> 8949420

Genotype-phenotype correlation in cystic fibrosis patients.

M Ferrari1, L Cremonesi.   

Abstract

Cystic fibrosis (CF) is the most common severe recessive disease in Caucasians. The gene responsible for the disease encodes a protein named cystic fibrosis transmembrane conductance regulator, which is predicted to function as a cAMP-regulated chloride channel. Reduced chloride secretion is at the basis of insufficient hydratation of ductural mucus in the airways, reproductive system and pancreas, leading to progressive obstructive damage. The clinical expression of the disease is heterogeneous but most CF patients typically present with chronic obstructive lung disease, elevated electrolyte concentration in sweat and insufficient pancreatic exocrine function. Approximately 10-15% of CF patients have pancreatic sufficiency, 2 to 5% of patients have liver disease and infertility is present in almost all adult males, due to congenital bilateral absence of the vas deferens, and frequently in females. To date, over 500 mutations have been identified in the CFTR gene. A genotype-phenotype correlation has been observed only with pancreas status, while severity of lung involvement is not clearly related to the CFTR genotype, suggesting that this phenotype might be modulated by additional genetic or environmental factors; liver disease in general is not genetically determined. A large proportion of sterile healthy men with congenital bilateral absence of the vas deferens carry a mutation in at least one of their CFTR genes. The data collected so far suggest that the relationship between the CFTR genotype and the clinical manifestation is multiple and complex.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8949420

Source DB:  PubMed          Journal:  Ann Biol Clin (Paris)        ISSN: 0003-3898            Impact factor:   0.459


  8 in total

Review 1.  Human Molecular Genetics and the long road to treating cystic fibrosis.

Authors:  Ann Harris
Journal:  Hum Mol Genet       Date:  2021-10-01       Impact factor: 5.121

Review 2.  Recent advances in understanding and managing cystic fibrosis transmembrane conductance regulator dysfunction.

Authors:  Uta Griesenbach; Eric W F W Alton
Journal:  F1000Prime Rep       Date:  2015-05-27

3.  In silico search for modifier genes associated with pancreatic and liver disease in Cystic Fibrosis.

Authors:  Pascal Trouvé; Emmanuelle Génin; Claude Férec
Journal:  PLoS One       Date:  2017-03-24       Impact factor: 3.240

4.  c.753_754delAG, a novel CFTR mutation found in a Chinese patient with cystic fibrosis: A case report and review of the literature.

Authors:  Yu-Qing Wang; Chuang-Li Hao; Wu-Jun Jiang; Yan-Hong Lu; Hui-Quan Sun; Chun-Yan Gao; Min Wu
Journal:  World J Clin Cases       Date:  2019-08-06       Impact factor: 1.337

5.  CF Patient's Pneumothoraxes Unique Genes.

Authors:  Jillian McKee; Joseph Majure; Hans Georg Bock; George Moll
Journal:  Glob Pediatr Health       Date:  2016-06-21

6.  Inhibition of NFkappaB by the natural product Withaferin A in cellular models of Cystic Fibrosis inflammation.

Authors:  Rangan Maitra; Melissa A Porter; Shan Huang; Brian P Gilmour
Journal:  J Inflamm (Lond)       Date:  2009-05-13       Impact factor: 4.981

7.  The CFTR M470V, intron 8 poly-T, and 8 TG-repeats detection in Chinese males with congenital bilateral absence of the vas deferens.

Authors:  Qiang Du; Zheng Li; Yongfeng Pan; Xiaoliang Liu; Bochen Pan; Bin Wu
Journal:  Biomed Res Int       Date:  2014-01-08       Impact factor: 3.411

Review 8.  Disease-modifying genes and monogenic disorders: experience in cystic fibrosis.

Authors:  Sabina Gallati
Journal:  Appl Clin Genet       Date:  2014-07-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.